Another podcast which would not seem to be interesting to testers, but could be is Dell in Biotech.
- Lab notebooks don’t scale – The big thing in the testing world seems to be carrying around moleskine notebooks. But any information in those are potentially lost when you leave it at the hotel, or is unaccessible if it is in your study in Toronto and you are in Seattle. And of course it is private. Private notes are certainly necessary, but some of the stuff really wants to be public. Wiki! Blog! Now!
- Chronology is subjective – Most of us work on multiple things/projects/whatever at one time. Our thoughts and discoveries are chronological to us, but since they are spread out and interleaved between multiple items they are not chronological to that thing.
- Hardware + Software + Services = Solution – I’m sure there is a testing linkage here somewhere, but I can’t find it right now. When they are talking about this they mention that customers don’t want finger pointing between vendors which seems like it might be close to what I am grasping for here.
- CFR 21 Part 11 – Practically speaking, Part 11 requires drug makers, medical device manufacturers, biotech companies, biologics developers, and other FDA-regulated industries, with some specific exceptions, to implement controls, including audits, system validations, audit trails, electronic signatures, and documentation for software and systems involved in processing electronic data that are (a) required to be maintained by the FDA predicate rules or (b) used to demonstrate compliance to a predicate rule. (source: Wikipedia)
- Scientist wants – This has been mentioned before, but to research scientist, they put in a sample in and they want information out. And they are not necessarily so concerned about what happens in the middle … they are more interested in the result of their … hypothesis
- Virtualization – a nice description of what it is and why you need to care
- Secret Handshake – If you don’t talk science, and research and data you won’t be able to work successfully with the scientific community